12.06
1.69%
0.20
Handel nachbörslich:
12.06
Schlusskurs vom Vortag:
$11.86
Offen:
$11.78
24-Stunden-Volumen:
263.38K
Relative Volume:
0.56
Marktkapitalisierung:
$679.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-96.66M
KGV:
-5.0041
EPS:
-2.41
Netto-Cashflow:
$-83.73M
1W Leistung:
+1.69%
1M Leistung:
+3.97%
6M Leistung:
+13.03%
1J Leistung:
-27.31%
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Firmenname
Olema Pharmaceuticals Inc
Sektor
Branche
Telefon
(415) 651-3316
Adresse
780 BRANNAN STREET, SAN FRANCISCO
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-01-30 | Eingeleitet | Citigroup | Buy |
2023-07-21 | Eingeleitet | Oppenheimer | Outperform |
2023-05-05 | Eingeleitet | CapitalOne | Overweight |
2023-02-22 | Eingeleitet | Credit Suisse | Outperform |
2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
2022-06-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2022-02-28 | Eingeleitet | H.C. Wainwright | Neutral |
2021-12-07 | Fortgesetzt | Cowen | Outperform |
2020-12-14 | Eingeleitet | Canaccord Genuity | Buy |
2020-12-14 | Eingeleitet | Cowen | Outperform |
2020-12-14 | Eingeleitet | JP Morgan | Overweight |
2020-12-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Recommendation of “Buy” by Brokerages - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation - Yahoo Finance
Possible Bearish Signals With Olema Pharmaceuticals Insiders Disposing Stock - Simply Wall St
SG Americas Securities LLC Acquires Shares of 13,056 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals (NASDAQ:OLMA) Earns Buy Rating from HC Wainwright - MarketBeat
Olema Pharmaceuticals maintains Buy rating from H.C. Wainwright By Investing.com - Investing.com UK
Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024 - The Manila Times
Insider Selling: Paradigm Biocapital Advisors L, Olema Pharmaceuticals Inc [OLMA] 10% Owner divested 2,400,000 shares – Knox Daily - Knox Daily
Closing Bell Recap: Olema Pharmaceuticals Inc (OLMA) Ends at 11.26, Reflecting a -1.23 Downturn - The Dwinnex
Can you still get a good price for Olema Pharmaceuticals Inc (OLMA) Shares at this point? - US Post News
Renaissance Technologies LLC Buys Shares of 53,200 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - The Manila Times
Point72 Asset Management L.P. Purchases New Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Aurigene Oncology, Olema Pharmaceuticals identify KAT6A inhibitors - BioWorld Online
Brokerages Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Target Price at $27.00 - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Dimensional Fund Advisors LP - Defense World
OLMA Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
OLMA underperforms with a -4.07 decrease in share price - US Post News
74,657 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Acquired by Dana Investment Advisors Inc. - MarketBeat
olema pharmaceuticals, inc. Earnings dates - RTTNews
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 3.8% - MarketBeat
Keeping an Eye on Olema Pharmaceuticals Inc (OLMA) After Insider Trading Activity - Knox Daily
Insider’s View: Deciphering Olema Pharmaceuticals Inc (OLMA)’s Financial Health Through Ratios - The Dwinnex
Long Term Trading Analysis for (OLMA) - Stock Traders Daily
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Marshall Wace LLP - Defense World
Ensign Peak Advisors Inc Acquires 850 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Affinity Asset Advisors LLC Purchases Shares of 275,000 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Affinity Asset Advisors LLC Invests $2.98 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Rhumbline Advisers Buys 17,953 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Logos Global Management LP - Defense World
Great Point Partners LLC Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Great Point Partners LLC Purchases New Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Examining the Potential Price Growth of Olema Pharmaceuticals Inc (OLMA) - Knox Daily
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 6.3% - Defense World
Taking the lead: Olema Pharmaceuticals Inc (OLMA) - SETE News
A Tale of Resilience: Olema Pharmaceuticals Inc Amid Stock Market Turbulence - The InvestChronicle
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Position Boosted by Bank of New York Mellon Corp - MarketBeat
Bank of New York Mellon Corp Acquires 58,622 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Market Insight: Olema Pharmaceuticals Inc (OLMA)’s Notable Gain, Closing at 12.27 - The Dwinnex
Olema Pharmaceuticals Inc’s results are impressive - US Post News
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Victory Capital Management Inc. - Defense World
Victory Capital Management Inc. Has $8.38 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Target Price at $27.00 - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Goldman initates Olema Pharmaceuticals Inc (OLMA) rating to a Buy - Knox Daily
Goldman Sachs maintains Buy rating on Olema Pharma shares with consistent target - Investing.com Canada
The Potential Rise in the Price of Olema Pharmaceuticals Inc (OLMA) following insiders activity - Knox Daily
Are Olema Pharmaceuticals Inc (OLMA) shares a good deal now? - US Post News
Candriam S.C.A. Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):